Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Dec;2(12):997-1005.
doi: 10.1007/s13238-011-1134-y. Epub 2012 Jan 10.

Structural vaccinology: structure-based design of influenza A virus hemagglutinin subtype-specific subunit vaccines

Chunling Xuan  1 , Yi Shi, Jianxun Qi, Wei Zhang, Haixia Xiao, George F Gao
Affiliations

Structural vaccinology: structure-based design of influenza A virus hemagglutinin subtype-specific subunit vaccines

Chunling Xuan et al. Protein Cell. 2011 Dec.

Erratum in

  • Protein Cell. 2012 Feb;3(2):160

Abstract

There is a great need for new vaccine development against influenza A viruses due to the drawbacks of traditional vaccines that are mainly prepared using embryonated eggs. The main component of the current split influenza A virus vaccine is viral hemagglutinin (HA) which induces a strong antibody-mediated immune response. To develop a modern vaccine against influenza A viruses, the current research has been focused on the universal vaccines targeting viral M2, NP and HA proteins. Crystallographic studies have shown that HA forms a trimer embedded on the viral envelope surface, and each monomer consists of a globular head (HA1) and a "rod-like" stalk region (HA2), the latter being more conserved among different HA subtypes and being the primary target for universal vaccines. In this study, we rationally designed the HA head based on the crystal structure of the 2009-pandemic influenza A (H1N1) virus HA as a model, tested its immunogenicity in mice, solved its crystal structure and further examined its immunological characteristics. The results show that the HA globular head can be easily prepared by in vitro refolding in an E. coli expression system, which maintains its intact structure and allows for the stimulation of a strong immune response. Together with recent reports on some similar HA globular head preparations we conclude that structure-based rational design of the HA globular head can be used for subtype-specific vaccines against influenza viruses.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Adams P.D., Grosse-Kunstleve R.W., Hung L.W., Ioerger T.R., McCoy A.J., Moriarty N.W., Read R.J., Sacchettini J.C., Sauter N.K., Terwilliger T.C. PHENIX: building new software for automated crystallographic structure determination. Acta Crystallogr D Biol Crystallogr. 2002;58:1948–1954. doi: 10.1107/S0907444902016657. - DOI - PubMed
    1. Beigel J.H., Farrar J., Han A.M., Hayden F.G., Hyer R., de Jong M. D., Lochindarat S., Nguyen T.K., Nguyen T.H., Tran T.H., the Writing Committee of the World Health Organization et al. Avian influenza A (H5N1) infection in humans. N Engl J Med. 2005;353:1374–1385. doi: 10.1056/NEJMra052211. - DOI - PubMed
    1. Belser J.A., Lu X., Maines T.R., Smith C., Li Y., Donis R.O., Katz J.M., Tumpey T.M. Pathogenesis of avian influenza (H7) virus infection in mice and ferrets: enhanced virulence of Eurasian H7N7 viruses isolated from humans. J Virol. 2007;81:11139–11147. doi: 10.1128/JVI.01235-07. - DOI - PMC - PubMed
    1. Belshe R.B., Gruber W.C., Mendelman P.M., Cho I., Reisinger K., Block S.L., Wittes J., Iacuzio D., Piedra P., Treanor J., et al. Efficacy of vaccination with live attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine against a variant (A/Sydney) not contained in the vaccine. J Pediatr. 2000;136:168–175. doi: 10.1016/S0022-3476(00)70097-7. - DOI - PubMed
    1. Bommakanti G., Citron M.P., Hepler R.W., Callahan C., Heidecker G.J., Najar T.A., Lu X., Joyce J.G., Shiver J.W., Casimiro D.R., et al. Design of an HA2-based Escherichia coli expressed influenza immunogen that protects mice from pathogenic challenge. Proc Natl Acad Sci U S A. 2010;107:13701–13706. doi: 10.1073/pnas.1007465107. - DOI - PMC - PubMed

Publication types

MeSH terms